Integra LifeSciences acquires Rebound Therapeutics — 4 things to know

Written by Alan Condon | September 09, 2019 | Print  |

Integra LifeSciences announced the acquisition of Rebound Therapeutics Sept. 9, adding the company’s minimally invasive neurosurgery system.

Four things to know:

1. The neurosurgery platform features integrated optics and illumination, enabling interfacing with OR monitors.

2. The technology expands Integra’s neurosurgical and therapeutic-focused portfolio.

3. Integra doesn’t anticipate the acquisition to have a material financial impact this year.

4. Financial terms of the deal were not disclosed.

More articles on devices:
'A dream come true': Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker's spine division stands to gain from 5 acquisitions 



 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months